Clinical variables | CKD1 | CKD2-3 | CKD4-5 | P |
---|---|---|---|---|
BUN(mmol/L,mean ± SD) | 5.71 ± 1.50 | 8.46 ± 3.53 | 25.29 ± 10.82 | > 0.001 |
Scr(umol/L,mean ± SD) | 81.16 ± 13.79 | 132.73 ± 34.41 | 423.69 ± 113.16 | > 0.001 |
Upro,n(%) | > 0.001 | |||
- | 57 | 49 | 1 | |
+ | 4 | 12 | 6 | |
+ + | 1 | 5 | 4 | |
+ + + | 0 | 1 | 1 | |
+ + + + | 0 | 1 | 1 | |
eGFR(ml/min/1.73m2,mean ± SD) | 124.75 ± 26.69 | 65.49 ± 14.84 | 18.16 ± 6.68 | > 0.001 |
Age(years, mean ± SD) | 34.45 ± 9.328 | 38.01 ± 9.40 | 42.38 ± 10.47 | 0.01 |
Weight (kg,mean ± SD) | 61.71 ± 9.39 | 59.10 ± 7.99 | 59.88 ± 7.31 | 0.107 |
Gender,n(%) | 0.009 | |||
Male | 55 | 41 | 9 | |
Female | 7 | 27 | 4 | |
Duration after renal transplant(days, mean ± SD) | 2661.53 ± 406.45 | 2711.21 ± 499.79 | 2770.92 ± 521.74 | 0.686 |
Incidence of DGF episodes, n (%) | 26 | 21 | 4 | 0.391 |
Incidence of AR episodes, n (%) | 22 | 27 | 5 | 0.883 |
Usage of RAPA, n (%) | 8 | 8 | 1 | 0.869 |
ISD protocol,n(%) | 0.634 | |||
CsA | 26 | 23 | 5 | |
FK506 | 36 | 45 | 8 |